ADMA Biologics, Inc.
Hedge Funds Holdings
Last updated:
ADMA Biologics, Inc.‘s stocks are currently a part of 99 hedge funds’ portfolios, which represents 29.23% of the total amount of its stocks outstanding. This makes up a total of 57.83M shares of ADMA Biologics, Inc.. Compared to the previous quarter, the number fell by -62.11% or -94.79M shares fewer. As for the holding position changes, 40.4% (40) of current hedge fund investors increased the number of shares held, 21.21% (21) of current holders sold a part of the shares held, and 11.11% (11) closed the holdings completely. 19 hedge funds are new holders of ADMA Biologics, Inc. stock in Q1 2023, it is 19.19% of total holders.
Hedge funds holding ADMA Biologics (Q2 2018 – Q1 2023)
| Q2 2018 | 55 |
|---|---|
| Q3 2018 | 57 |
| Q4 2018 | 50 |
| Q1 2019 | 54 |
| Q2 2019 | 67 |
| Q3 2019 | 71 |
| Q4 2019 | 74 |
| Q1 2020 | 91 |
| Q2 2020 | 95 |
| Q3 2020 | 91 |
| Q4 2020 | 90 |
| Q1 2021 | 99 |
| Q2 2021 | 85 |
| Q3 2021 | 68 |
| Q4 2021 | 84 |
| Q1 2022 | 101 |
| Q2 2022 | 108 |
| Q3 2022 | 127 |
| Q4 2022 | 161 |
| Q1 2023 | 99 |
Hedge funds changes in ADMA Biologics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 31 | 17 | 3 | 9 | -5 |
|---|---|---|---|---|---|
| Q3 2018 | 7 | 23 | 12 | 5 | 10 |
| Q4 2018 | 8 | 16 | 16 | 14 | -4 |
| Q1 2019 | 11 | 15 | 11 | 6 | 11 |
| Q2 2019 | 18 | 32 | 7 | 3 | 7 |
| Q3 2019 | 11 | 38 | 10 | 6 | 6 |
| Q4 2019 | 16 | 32 | 15 | 12 | -1 |
| Q1 2020 | 27 | 41 | 14 | 10 | -1 |
| Q2 2020 | 20 | 32 | 27 | 16 | 0 |
| Q3 2020 | 17 | 25 | 38 | 19 | -8 |
| Q4 2020 | 18 | 36 | 22 | 18 | -4 |
| Q1 2021 | 25 | 35 | 25 | 17 | -3 |
| Q2 2021 | 16 | 21 | 35 | 30 | -17 |
| Q3 2021 | 6 | 19 | 27 | 23 | -7 |
| Q4 2021 | 29 | 23 | 21 | 13 | -2 |
| Q1 2022 | 24 | 33 | 23 | 7 | 14 |
| Q2 2022 | 34 | 30 | 26 | 26 | -8 |
| Q3 2022 | 30 | 41 | 33 | 11 | 12 |
| Q4 2022 | 45 | 52 | 38 | 8 | 18 |
| Q1 2023 | 19 | 40 | 21 | 11 | 8 |
Hedge funds changes in ADMA Biologics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 5,000 | 0 |
| Q4 2018 | 2,000 | 2,000 |
| Q1 2019 | 297,000 | 1,811,000 |
| Q2 2019 | 303,000 | 128,000 |
| Q3 2019 | 495,000 | 230,000 |
| Q4 2019 | 107,000 | 128,000 |
| Q1 2020 | 1,990,000 | 1,407,000 |
| Q2 2020 | 1,420,000 | 1,628,000 |
| Q3 2020 | 1,602,000 | 2,054,000 |
| Q4 2020 | 1,154,000 | 2,079,000 |
| Q1 2021 | 1,526,000 | 3,788,000 |
| Q2 2021 | 712,000 | 3,487,000 |
| Q3 2021 | 473,000 | 2,138,000 |
| Q4 2021 | 632,000 | 2,119,000 |
| Q1 2022 | 817,000 | 382,000 |
| Q2 2022 | 1,471,000 | 607,000 |
| Q3 2022 | 3,824,000 | 965,000 |
| Q4 2022 | 11,154,688 | 1,384,960 |
| Q1 2023 | 449,725,000 | 153,474,000 |